Log In
Monday 24th June 2019

Pill for MS offered to British sufferers

16th March 2012

The National Institute for Health and Clinical excellence (NICE) has approved the drug fingolimod which could help thousands of people with MS.

Fingolimod which can halve relapses compared with standard interferon injections and experts hope the once-a-day pill will replace injections and hospital infusions for at least 5,000 sufferers a year. While initially considering the drug was not value for money despite admitting it works, NICE has now considered extra evidence on its effectiveness and decided to give the go-ahead for use on the NHS.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2019